RNAi

Novo Nordisk Restructures R&D Services in the US

Danish pharma Novo Nordisk is expanding its R&D capabilities in Boston, Massachusetts, US, which will lead to the closure of a facility in Indianapolis and a restructuring of its Seattle operations.

Boehringer Ingelheim and Dicerna in NASH Pact

Nanotech Robots Deliver Gene Therapy Through Blood